| Released | Contributor | Author | Title | Pages | Price |
| 6-Dec-2009 | PriceTarget Research, Inc. |
N/A
| Obagi Med Products has a current Overall Rating of A (Highest Rating). | 7 |
$25 |
| 6-Dec-2009 | Wright Reports |
N/A
| Wright Industry Averages: Health, Medicine and Pharmaceuticals (United States) | 101 |
$169 |
| 6-Dec-2009 | Wright Reports |
N/A
| Wright Industry Averages: Health, Medicine and Pharmaceuticals (North America) | 103 |
$169 |
| 4-Dec-2009 | Pechala's Reports | Frantisek Pechala | OBAGI MEDICAL PRODUCTS INC (OMPI=US) 12-months forecast | 1 |
$15 |
| 4-Dec-2009 | Pechala's Reports | Lubomir Pechala | OBAGI MEDICAL PRODUCTS INC (OMPI=US) 2-weeks forecast | 1 |
$10 |
| 4-Dec-2009 | New Constructs, LLC |
N/A
| OMPI: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings | 19 |
$10 |
| 4-Dec-2009 | Pechala's Reports | Lubomir Pechala | OBAGI MEDICAL PRODUCTS INC (OMPI=US) - REPORT FOR ACTIVE TRADERS | 4 |
$25 |
| 3-Dec-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for HOME HEALTH CARE | 18 |
$49 |
| 3-Dec-2009 | Ford Investor Services, Inc. |
N/A
| Industry Value Graph: ACOR , AFFY , ANDS , BSTC , OMPI , TELK -- DRUGS | 3 |
$4 |
| 3-Dec-2009 | Ford Investor Services, Inc. |
N/A
| Value Graph: OBAGI MEDICAL -- OMPI | 1 |
$4 |
0.22% Nasdaq 
Research Reports
